Revelation Biosciences Inc
REVB
Revelation Biosciences Inc AI Insights
Informational only. Not investment advice.Snapshot
- Zero revenue pre-clinical biotech burning 10M TTM cash with 12.7M remaining - ~15 months runway at current rate.[Cash and Equivalents]
- Market cap 2.3M vs book value 11M (P/B 0.21) - trading at 79% discount to liquidation value.[Price to Book Ratio]
- Negative enterprise value (-10.4M) signals market pricing in cash burn exceeding equity value.[Enterprise Value]
Watch Triggers
- Cash and Equivalents: Falls below 6M (6-month runway) — Triggers forced financing at likely unfavorable terms or strategic alternatives.
- Issuance of Capital Stock: Any new equity issuance — Dilution magnitude determines whether book value discount persists.
- Research and Development TTM: Significant increase or decrease from 3.7M — Signals pipeline acceleration (burn faster) or wind-down (preserve cash).
Bull Case
Trading at 21% of book value with 12.7M cash - downside protected if liquidation occurs above current market cap of 2.3M.
Negative EV (-10.4M) means any pipeline success or M&A premium delivers asymmetric upside from 2.6M share base.
Bear Case
Zero revenue biotech with 15-month runway will require dilutive financing - 2.6M shares could multiply significantly.
ROE of -119% and ROIC of -119% TTM indicate capital destruction with no visibility to profitability.
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage REVB's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Cash runway exhaustion by mid-2026 forces binary outcome: dilutive raise or strategic transaction.
- 10M annual cash burn rate TTM
- 12.7M current cash position
- Zero revenue generation
Public Strategies Rankings
See how Revelation Biosciences Inc ranks across different investment strategies.
Leverage REVB's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
REVB Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$2.3M | — | ||
$-10.41M | — | ||
0.01 | — | ||
$0 | — | ||
$81.25 | — | ||
0% | 0.0% | — | |
0% | 0.0% | — | |
$-10.03M | — | ||
-1.2 | +151.1% | — | |
Beta 5Y (Monthly) | unknown | — |
REVB Dividend History
REVB Stock Splits
REVB SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
11/06/25 | 09/30/25 | 10-Q | |
08/08/25 | 06/30/25 | 10-Q | |
05/08/25 | 03/31/25 | 10-Q | |
03/06/25 | 12/31/24 | Unknown | |
11/08/24 | 09/30/24 | 10-Q | |
09/23/24 | 06/30/24 | 10-Q/A | |
08/09/24 | 06/30/24 | 10-Q | |
05/10/24 | 03/31/24 | 10-Q | |
09/23/24 | 03/31/24 | 10-Q/A | |
03/22/24 | 12/31/23 | 10-K | |
11/09/23 | 09/30/23 | 10-Q | |
08/11/23 | 06/30/23 | 10-Q | |
09/23/24 | 06/30/23 | 10-Q/A | |
05/22/23 | 03/31/23 | 10-Q | |
09/23/24 | 03/31/23 | 10-Q/A | |
03/30/23 | 12/31/22 | 10-K | |
11/10/22 | 09/30/22 | 10-Q | |
08/15/22 | 06/30/22 | 10-Q | |
05/16/22 | 03/31/22 | 10-Q | |
02/01/23 | 12/31/21 | S-1/A | |
12/16/21 | 09/30/21 | 424B3 | |
08/15/22 | 06/30/21 | 10-Q | |
05/16/22 | 03/31/21 | 10-Q |